BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35952620)

  • 1. Derivation of spinocerebellar ataxia type 3 human embryonic stem cell line UMICHe001-A/UM134-1.
    Moore LR; Keller L; Paulson HL; Smith GD
    Stem Cell Res; 2022 Oct; 64():102873. PubMed ID: 35952620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.
    Moore LR; Keller L; Bushart DD; Delatorre RG; Li D; McLoughlin HS; do Carmo Costa M; Shakkottai VG; Smith GD; Paulson HL
    Stem Cell Res; 2019 Aug; 39():101504. PubMed ID: 31374463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
    Hayer SN; Schelling Y; Huebener-Schmid J; Weber JJ; Hauser S; Schöls L
    Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human embryonic stem cell line chHES-472 from abnormal embryos diagnosed with Spinocerebellar ataxia type 3.
    Liu L; Zeng S; Sun Y; Zhou X; Chen J; Du J; Lu G; Lin G; Ouyang Q
    Stem Cell Res; 2016 Nov; 17(3):584-586. PubMed ID: 27934588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of human iPS cell line IBCHi002-A from spinocerebellar ataxia type 3/Machado-Joseph disease patient's fibroblasts.
    Ciolak A; Krzyzosiak WJ; Kozlowska E; Fiszer A
    Stem Cell Res; 2020 May; 45():101796. PubMed ID: 32361312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
    Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
    Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.
    Soong BW; Syu SH; Wen CH; Ko HW; Wu ML; Hsieh PC; Hwang SM; Lu HE
    Stem Cell Res; 2017 Jan; 18():29-32. PubMed ID: 28395798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
    Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
    J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
    Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
    Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
    Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
    Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3.
    Wang Y; Sun H; Wang Z; Yue Y; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2019 Dec; 41():101564. PubMed ID: 31639609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
    Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
    Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.
    Gan SR; Ni W; Dong Y; Wang N; Wu ZY
    PLoS One; 2015; 10(8):e0134405. PubMed ID: 26266536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
    Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
    PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
    Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
    Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
    Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
    Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.